Abstract
TRPA1 is a promising target for the development of novel treatments for chronic pain. In this issue of Neuron, Liu et al. (2021) report a novel non-covalent TRPA1-biased agonist, GNE551, revealing a unique binding pocket by cryo-EM and activation properties that pave a path toward new avenues in the treatment of chronic pain.
Original language | English (US) |
---|---|
Pages (from-to) | 194-196 |
Number of pages | 3 |
Journal | Neuron |
Volume | 109 |
Issue number | 2 |
DOIs | |
State | Published - Jan 20 2021 |
ASJC Scopus subject areas
- Neuroscience(all)